切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2017, Vol. 04 ›› Issue (04) : 213 -217. doi: 10.3877/cma.j.issn.2095-8773.2017.04.04

所属专题: 文献

论著

内镜黏膜下剥离术治疗黏膜肌层或下层食管癌的短期疗效分析
李斌1, 杨煜1, 孙益峰1, 华荣1, 叶波1, 顾海勇1, 李志刚1,()   
  1. 1. 200030 上海交通大学附属胸科医院胸外科 上海交通大学食管疾病诊治中心
  • 收稿日期:2017-09-10 出版日期:2017-11-28
  • 通信作者: 李志刚

Retrospective analysis of short-term results of endoscopic submucosal dissection in the treatment of superficial esophageal cancer invading into the muscularis mucosa or submucosa

Bin Li1, Yu Yang1, Yifeng Sun1, Rong Hua1, Bo Ye1, Haiyong Gu1, Zhigang Li1,()   

  1. 1. Department of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China
  • Received:2017-09-10 Published:2017-11-28
  • Corresponding author: Zhigang Li
  • About author:
    Corresponding author: Li Zhigang, Email:
引用本文:

李斌, 杨煜, 孙益峰, 华荣, 叶波, 顾海勇, 李志刚. 内镜黏膜下剥离术治疗黏膜肌层或下层食管癌的短期疗效分析[J/OL]. 中华胸部外科电子杂志, 2017, 04(04): 213-217.

Bin Li, Yu Yang, Yifeng Sun, Rong Hua, Bo Ye, Haiyong Gu, Zhigang Li. Retrospective analysis of short-term results of endoscopic submucosal dissection in the treatment of superficial esophageal cancer invading into the muscularis mucosa or submucosa[J/OL]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2017, 04(04): 213-217.

目的

探讨内镜黏膜下剥离术(ESD)治疗黏膜肌层或黏膜下层侵犯食管鳞癌的指证选择和早期结果。

方法

收集上海市胸科医院食管外科2014年6月—2017年6月行ESD治疗的食管鳞癌患者资料,选取其中病理侵犯深度至黏膜肌层或黏膜下层(T1a-M3~T1b)的22例患者,病变位于食管中段16例,食管下段6例。分析患者的一般资料、术后并发症、综合治疗以及短期随访结果。

结果

22例食管鳞癌患者中,行R0切除10例(45.5%);R1切除12例,其中基底切缘阳性3例,侧切缘阳性9例;标本病理分型T1a-M3 9例(40.9%),T1b 13例(59.1%)。术后中位随访时间6.0个月,随访过程中并发食管狭窄行内镜下扩张术3例(13.6%)。术后再治疗患者7例,4例接受挽救性手术(其中1例为术后6个月复发后再次手术),3例接受放化疗。手术切除情况与肿瘤浸润深度相关(P=0.0274),与病变长度无相关性(P=0.2659)。

结论

ESD切除结合放化疗可作为黏膜肌层或黏膜下层侵犯早期食管癌的治疗选择,手术切除情况与肿瘤浸润深度密切相关,与病变长度无相关性。

Objective

To discuss the choices and early results of endoscopic submucosal dissection(ESD) treatment of muscularis mucosal or submucosal invasion of esophageal squamous cell carcinoma.

Methods

The clinical data of patients with esophageal squamous cell carcinoma undergoing ESD surgery in Shanghai Chest Hospital between June 2014 and June 2017 were reviewed. The pathological invasion of 22 cases is the muscularis mucosa or submucosa (T1a-M3-T1b). In 16 cases the lesions were located in the middle esophagus and 6 cases in the lower esophagus. The general information, postoperative complications, comprehensive treatment, and short-term follow-up results were analyzed.

Results

Among 22 cases, 10 cases (45.5%) underwent R0 resection, and 12 cases underwent R1 resection, including 3 cases of basal margin positive, 9 cases of lateral margin positive; there were 9 cases (40.9%) of T1a-M3 of the pathological type of specimens, and 13 cases (59.1%) of T1b. The follow-up time was 0.9-19.9 months, and the median time was 6 months. 3 cases (13.6%) underwent endoscopic dilatation during esophageal stenosis. In 7 patients who were followed up for surgery, 4 patients received salvage surgery (1 case receiving recurrent surgery after 6 months), and 3 patients received radiotherapy and chemotherapy. Surgical resection was associated with depth of tumor invasion (P = 0.0274) and had no correlation with lesion length (P=0.2659).

Conclusions

ESD combined with chemoradiotherapy can be regarded as a good choice for the treatment of superficial esophageal cancer invading into the muscularis mucosa or submucosa. The resection rate is closely related to the depth of tumor invasion, and is not related to the length of the lesion.

表1 一般病例资料
表2 ESD患者手术切除情况与肿瘤浸润深度和病变长度的关系
1
Yamasaki Y, Takenaka R, Hori K, et al. Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening [J]. World J Gastroenterol, 2015,21(9): 2793-2799.
2
Kuraoka K, Hoshino E, Tsuchida T, et al. Early esophageal cancer can be detected by screening endoscopy assisted with narrow-band imaging (NBI) [J]. Hepatogastroenterology, 2009,56(89): 63-66.
3
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society [J]. Esophagus, 2015,12: 1-30.
4
马丹,杨帆,廖专,等. 中国早期食管癌筛查及内镜诊治专家共识意见(2014年,北京) [J]. 中国实用内科杂志,2015, (04): 320-337.
5
Li B, Chen H, Xiang J, et al. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma [J]. J Thorac Cardiovasc Surg, 2013,146(5): 1198-1203.
6
Qi X, Li M, Zhao S, et al. Prevalence of metastasis in T1b esophageal squamous cell carcinoma: a retrospective analysis of 258 Chinese patients [J]. J Thorac Dis, 2016,8(5): 966-976.
7
Thosani N, Singh H, Kapadia A, et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis [J]. Gastrointest Endosc, 2012,75(2): 242-253.
8
Yip HC, Chiu PW. Endoscopic diagnosis and management of early squamous cell carcinoma of esophagus [J]. J Thorac Dis, 2017,9(Suppl 8): S689-S696.
9
Makuuchi H. Endoscopic mucosal resection for mucosal cancer in the esophagus [J]. Gastrointest Endosc Clin N Am, 2001,11(3): 445-458.
10
Ballard DD, Choksi N, Lin J, et al. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection [J]. World J Gastrointest Endosc, 2016,8(20): 763-769.
11
Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer [J]. Clin Gastroenterol Hepatol, 2005,3(7 Suppl 1): S67-70.
12
Yamada K, Murakami M, Okamoto Y, et al. Treatment results of chemoradiotherapy for clinical stage Ⅰ (T1N0M0) esophageal carcinoma [J]. Int J Radiat Oncol Biol Phys, 2006,64(4): 1106-1111.
13
Ikeda A, Hoshi N, Yoshizaki T, et al. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion [J]. Intern Med, 2015,54(22): 2803-2813.
14
Mochizuki Y, Saito Y, Tsujikawa T, et al. Combination of endoscopic submucosal dissection and chemoradiation therapy for superficial esophageal squamous cell carcinoma with submucosal invasion [J]. Exp Ther Med, 2011,2(6): 1065-1068.
15
Lee HJ, Lee H, Park JC, et al. Treatment strategy after endoscopic resection of superficial esophageal squamous cell carcinoma: a single institution experience [J]. Gut Liver, 2015,9(6): 714-719.
16
Kawaguchi G, Sasamoto R, Abe E, et al. The effectiveness of endoscopic submucosal dissection followed by chemo-radiotherapy for superficial esophageal cancer [J]. Radiat Oncol, 2015,10: 31.
[1] 兰华, 高丽莎, 申明, 张铭光. 内镜黏膜下剥离术后溃疡出血的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 467-469.
[2] 李绍杰, 谢奇峰, 李绍春, 杨子昂, 黄永刚, 陈吉彩, 杜舟, 王平, 张剑, 唐健雄. 复合基底膜生物补片应用于腹股沟疝Lichtenstein修补术的随机、对照、多中心临床研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(02): 132-138.
[3] 郭小琦, 张璞, 李小军, 余明, 王博. 口服醋酸泼尼松联合局部注射曲安奈德对食管早癌ESD术后食管狭窄及肺部感染的预防疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 288-291.
[4] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[5] 刘晗, 李惠, 朱宇新, 于淼, 李莞盈, 王爽, 狄育竹, 宁丹丹, 曲波. 新型生物材料在内镜黏膜下剥离术中的应用[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(03): 167-171.
[6] 陈磊, 高苏俊, 王璐, 倪修凡, 史茜菁, 朱振. 糖皮质激素序贯疗法预防环周食管浅表肿瘤内镜黏膜下剥离术后狭窄的研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 159-165.
[7] 陶海燕, 金晓维, 郁海静, 欧阳皓, 张娟, 张海芳. 行内镜黏膜下的剥离术治疗老年大肠侧向发育型肿瘤的临床观察[J/OL]. 中华临床医师杂志(电子版), 2023, 17(11): 1137-1141.
[8] 陈柯豫, 黄艳齐, 张玲利. 同时性多发早期食管癌及高级别上皮内瘤变的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(05): 524-528.
[9] 吴慧银, 刘晓冰, 杜康, 杜健, 王盈盈, 陈炫. ESD 治疗伴发食管胃静脉曲张的食管早癌及癌前病变围术期护理经验[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 273-275.
[10] 曹友红, 吕翔, 张康伟, 袁晨, 徐甜, 唐月华, 马亦旻, 邢一鸣, 张以洋. 基于EUS 引导下ESD 对食管上皮下鱼刺的治疗[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 243-247.
[11] 胡兵. 食道早癌内镜黏膜下剥离术(ESD)[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 216-216.
[12] 张其德. 内镜下精准肌层剥离术在伴有黏膜下层纤维化/疤痕的早期胃癌治疗的作用初探(视频)[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 144-144.
[13] 倪修凡, 陈磊, 印健, 张利, 高苏俊, 朱振. 内镜下不同术式治疗直肠神经内分泌肿瘤临床研究[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(03): 173-179.
[14] 曹友红, 马亦旻, 张康伟, 孔令超, 徐甜, 邢一鸣, 吕奇珠, 姜云方, 徐桂芳. 内镜下新型金属夹联合圈套器辅助内镜下黏膜切除术治疗直肠神经内分泌瘤疗效及安全性分析[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(01): 41-45.
[15] 齐凤祥, 齐向娟. 内镜黏膜下剥离术治疗老年人早期胃癌疗效分析[J/OL]. 中华老年病研究电子杂志, 2023, 10(04): 18-22.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?